This was initially detected in T-ALL where the generation of de novo MYB binding sites in the upstream region of the TAL1 oncogene creates a MYB-dependent neo-enhancer driving the expression of TAL1 [39]. The gene discussed is MYB; the disease is acute lymphoblastic leukemia.